Related Experiment Video
Updated: Feb 14, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two
Peng Ye1, Cheng Fang1, Hui Zeng1
1Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Abstract:
Tamoxifen (TAM) resistance has become a severe problem for endocrine therapy of breast cancer. The present study investigated the association between microRNA (miRNA) expression and TAM resistance in breast cancer. The TAM-resistant breast cancer MCF-7C and MCF-7T cell lines were established using the human breast cancer cell line MCF-7 as the parental cell line and 4-hydroxytamoxifen (OHT) as the screening drug in vitro. The MCF-7C cell line was established by dose stepwise induction beginning with a low concentration of OHT; the MCF-7T cell line was established by temporal stepwise induction beginning with a high concentration of OHT. Differential miRNA expression profiles between TAM-sensitive (MCF-7) and TAM-resistant (MCF-7C and MCF-7T) breast cancer cell lines were detected and analyzed using RNA sequencing technology. The results of western blot analysis indicated that the level of ERα protein expression in drug-resistant cells was significantly increased. A total of 1,646 miRNAs were detected in all samples, including 1,376 known miRNAs and 270 predicted miRNAs. There were 118 miRNAs expressed at significantly different levels between MCF-7C and MCF-7 cells (P<0.05); among them, 67 miRNAs were upregulated (P<0.05) and 51 miRNA were downregulated (P<0.05). There were 42 miRNAs expressed at significantly different levels between MCF-7T and MCF-7 (P<0.05); among them, 23 miRNAs were upregulated (P<0.05) and 19 miRNAs were downregulated (P<0.05). There were 126 miRNAs with significant differences between MCF-7C and MCF-7T (P<0.05); among them, 76 miRNAs were upregulated (P<0.05) and 50 miRNAs were downregulated. On the basis of the results of the present study, we hypothesize that miR-21, miR-146a, miR-148a, miR-34a and miR-27a may serve important roles in mediating TAM resistance in breast cancer, and have potential as therapeutic targets for TAM-resistant breast cancer.
Insights
Tamoxifen resistance in breast cancer is a major challenge. This study identifies specific microRNAs (miRNAs) linked to tamoxifen resistance, suggesting potential new therapeutic targets for resistant breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tamoxifen (TAM) resistance poses a significant obstacle in endocrine therapy for breast cancer.
- Understanding the molecular mechanisms underlying TAM resistance is crucial for developing effective treatment strategies.
Purpose of the Study:
- To investigate the association between microRNA (miRNA) expression profiles and tamoxifen (TAM) resistance in breast cancer.
- To identify specific miRNAs that may play a role in mediating TAM resistance.
Main Methods:
- Established tamoxifen-resistant breast cancer cell lines (MCF-7C and MCF-7T) from parental MCF-7 cells using 4-hydroxytamoxifen (OHT) in vitro.
- Analyzed differential miRNA expression profiles between sensitive and resistant cell lines using RNA sequencing technology.
- Confirmed ERα protein expression levels using western blot analysis.
Main Results:
- Identified significant differences in miRNA expression between TAM-sensitive and TAM-resistant cell lines.
- Detected 118 differentially expressed miRNAs between MCF-7C and MCF-7 cells, and 42 between MCF-7T and MCF-7 cells.
- Observed increased ERα protein expression in drug-resistant cells.
Conclusions:
- Hypothesize that specific miRNAs, including miR-21, miR-146a, miR-148a, miR-34a, and miR-27a, are involved in mediating TAM resistance in breast cancer.
- These identified miRNAs represent potential therapeutic targets for overcoming tamoxifen resistance in breast cancer patients.
More Related Videos
10:51Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines
Published on: March 22, 2015
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
MicroRNAs
MicroRNAs
Treatment Resistant Cancers
Cell Lines
Cell Specific Gene Expression
Induced Pluripotent Stem Cells